Medical News

ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration 2022

13. 5. 2022 Source: Primary and Secondary Immunodeficiencies

For the second time, a two-day meeting titled "ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration" took place, this time on March 25–26, 2022, in Prague. Several current topics were discussed during this professional event, which brings together experts who care for patients with primary or secondary immunodeficiencies. The meeting was professionally guaranteed by Prof. MUDr. Anna Šedivá, DSc., from the Institute of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital Motol in Prague.

According to which parameters can we best assess the quality of incontinence aids?

Properly chosen incontinence aid significantly influences the user's quality of life. When selecting incontinence aids, it is very important to consider their individual properties and parameters.…

12. 5. 2022 Source: Incontinence

Inkontinence_inkontinenční_pomůcky_únik_moči

Correct Selection of Appropriate Incontinence Aid is Crucial for Addressing Patient's Difficulties

Urinary incontinence is an uncomfortable issue that can be resolved by choosing the right incontinence aids. Selecting a quality product is most important for the patient −⁠ it affects their comfort…

12. 5. 2022 Source: Incontinence

Experience from Clinical Practice with Intestinal Gel LECIG in Treating Parkinson's Disease

A Swedish observational study evaluated the applicability of the LECIG intestinal gel, which contains levodopa (20 mg/ml), carbidopa (5 mg/ml), and entacapone (20 mg/ml), in clinical practice for…

12. 5. 2022 Source: Parkinson's Disease

Eletriptan and Its Role in Acute Migraine Therapy

In the acute treatment of moderate to severe migraine attacks, medications from the triptan group are primarily used. The following article summarizes important findings about eletriptan and its key…

10. 5. 2022 Source: Treatment of Severe Migraine

Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Plaque Psoriasis -⁠ BE READY Study Results

The interleukin 17 (IL-17) family represents a group of pro-inflammatory cytokines that play a crucial role in the pathogenesis of psoriasis. Inhibiting interleukins from this family has a…

6. 5. 2022 Source: Psoriasis

Current View on the Issue of Protein Intake in Critically Ill Patients

A summary of current knowledge and guidelines concerning the nutritional needs of critically ill patients presented last year in the journal Clinical Nutrition deals with protein intake, specifically…

5. 5. 2022 Source: Parenteral Nutrition

Reduction of Mortality in Patients After Abdominal Surgery in Critical Condition Thanks to Early Supplemental Parenteral Nutrition

Ensuring adequate nutrition is an important part of therapy for critically ill patients to achieve better clinical outcomes in terms of both survival and recovery speed. The preferred option is…

5. 5. 2022 Source: Parenteral Nutrition

Empagliflozin Secures Reimbursement for Heart Failure Treatment

Starting May 1st, health insurance companies will cover Jardiance^® (empagliflozin) for patients with heart failure with reduced ejection fraction. Cardiologists, pediatric cardiologists,…

3. 5. 2022 Source: Heart Failure

Gut-Brain Axis −⁠ Future of MS Treatment?

The relationship between the gut microbiome and multiple sclerosis has been a major topic recently. How far has current science progressed in decoding this issue? A recent review article published in…

3. 5. 2022 Source: Multiple Sclerosis

1 … 75 76 77 78 79 … 164

Back Filter by speciality

Remove filters